Ireland · Who invested in ProVerum Medical?
ProVerum Medical's investors include MVM Life Science Partners, OrbiMed, Enterprise Ireland, Atlantic Bridge and GIC, and 3 more on record. MVM Life Science Partners led its latest round.
Ireland · Series B startup
Who invested in ProVerum Medical
One round we have observed, with the 8 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$80Mraised across 1 round since 2025, from 2 sources
- Latest round
- Series B, $80MAug 2025
- Led by
- MVM Life Science Partners
- Investors
- 8 (1 led)
The rounds
- Aug 2025Series B$80M
MVM Life Science PartnersLead
OrbiMedEnterprise Ireland
Atlantic Bridge
GIC
Lightstone Ventures
Ireland Strategic Investment Fund- Gilde Healthcare Partners
Reported by Crunchbase News and 1 other
Everyone who backed them
Gilde Healthcare PartnersGrowth equity1round
Missing a round, or an investor who was in one? Tell us.
Quick answers about ProVerum Medical
How much has ProVerum Medical raised?
ProVerum Medical has raised $80M across 1 round since 2025.
When did ProVerum Medical last raise?
ProVerum Medical's most recent round was a Series B of $80M in Aug 2025, led by MVM Life Science Partners.
What was ProVerum Medical's biggest round?
Its most recent round, $80M in Aug 2025, is also its largest on record.
Who backed ProVerum Medical first?
ProVerum Medical's first round on record, in Aug 2025, was backed by MVM Life Science Partners, OrbiMed and Enterprise Ireland and 5 others.
What stage is ProVerum Medical at?
ProVerum Medical's latest named round is a Series B, in Aug 2025.
Where is ProVerum Medical based?
ProVerum Medical is based in Ireland.
Who led ProVerum Medical's rounds?
MVM Life Science Partners led the Series B in 2025.
Companies like ProVerum Medical
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.